3,198
Views
3
CrossRef citations to date
0
Altmetric
Musculoskeletal

The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystonia

, &
Pages 919-929 | Received 11 Mar 2022, Accepted 17 Jun 2022, Published online: 15 Jul 2022